Mutational analysis of flucytosine resistance in Candida glabrata

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4733-4738

  Edlind, Thomas D ^a   Katiyar, Santosh K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA GLABRATA; DRUG BLOOD LEVEL; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, FUNGAL; FLUCYTOSINE; FUNGAL PROTEINS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 78049272779     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00605-10     Document Type: Article

References (33)

1. Chapeland-Leclerc, F., C. Hennequin, N. Papon, T. Noël, A. Girard, G. Socié, P. Ribaud, and C. Lacroix. 2010. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob. Agents Chemother. 54:1360-1362.
2. Dodgson, A. R., K. J. Dodgson, C. Pujol, M. A. Pfaller, and D. R. Soll. 2004. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48:2223-2227.
3. Erbs, P., F. Exinger, and R. Jund. 1997. Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr. Genet. 31:1-6.
4. Fasoli, M. O., and D. Kerridge. 1990. Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans. J. Gen. Microbiol. 136:1475-1481.
5. Florent, M., T. Noel, G. Ruprich-Robert, B. Da Silva, V. Fitton-Ouhabi, C. Chastin, N. Papon, and F. Chapeland-Leclerc. 2009. Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae. Antimicrob. Agents Chemother. 53:2982-2990.
6. Garcia-Effron, G., S. Lee, S. Park, J. D. Cleary, and D. S. Perlin. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699.
7. Hope, W. W., L. Tabernero, D. W. Denning, and M. J. Anderson. 2004. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob. Agents Chemother. 48:4377-4386.
8. Ireton, G. C., M. E. Black, and B. L. Stoddard. 2003. The 1.14 Å crystal structure of yeast cytosine deaminase: evolution of nucleotide salvage enzymes and implications for genetic chemotherapy. Structure 11:961-972.
9. Jund, R., and F. Lacroute. 1970. Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J. Bacteriol. 102:607-615.
10. Katiyar, S. K., and T. D. Edlind. 2009. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 53:1772-1778.
11. Kern, L., J. de Montigny, R. Jund, and F. Lacroute. 1990. The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles. Gene 88:149-157.
12. Kern, L., J. de Montigny, F. Lacroute, and R. Jund. 1991. Regulation of the pyrimidine salvage pathway by the FUR1 gene product of Saccharomyces cerevisiae. Curr. Genet. 19:333-337.
13. Ko, T. P., J. J. Lin, C. Y. Hu, Y. H. Hsu, A. H. Wang, and S. H. Liaw. 2003. Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution. J. Biol. Chem. 278:19111-19117.
14. Koren, A., S. Ben-Aroya, R. Steinlauf, and M. Kupiec. 2003. Pitfalls of the synthetic lethality screen in Saccharomyces cerevisiae: an improved design. Curr. Genet. 43:62-69.
15. Krogh, A., B. Larsson, G. von Heijne, and E. L. L. Sonnhammer. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580.
16. Lewis, R. E. 2009. Overview of the changing epidemiology of candidemia. Curr. Med. Res. Opin. 25:1732-1740.
17. Li, L., S. Redding, and A. Dongari-Bagtzoglou. 2007. Candida glabrata: an emerging oral opportunistic pathogen. J. Dent. Res. 86:204-215.
18. McManus, B. A., G. P. Moran, J. A. Higgins, D. J. Sullivan, and D. C. Coleman. 2009. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 53:4678-4685.
19. Paluszynski, J. P., R. Klassen, M. Rohe, and F. Meinhardt. 2006. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Yeast 23:707-715.
20. Pfaller, M. A., and D. J. Diekema. 2007. The epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
21. Pfaller, M. A., S. A. Messer, L. Boyken, H. Huynh, R. J. Hollis, and D. J. Diekema. 2002. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46:3518-3521.
22. Pfaller, M. A., S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, G. V. Doern, and D. J. Diekema. 2005. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J. Clin. Microbiol. 43:2163-2167.
23. Pujol, C., M. A. Pfaller, and D. R. Soll. 2004. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob. Agents Chemother. 48:262-266.
24. Quindós, G., M. T. Ruesga, E. Martín-Mazuelos, R. Salesa, R. Alonso-Vargas, A. J. Carrillo-Muñoz, S. Brena, R. San Millán, and J. Pontón. 2004. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev. Iberoam. Micol. 21:63-69.
25. Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 30:2155-2162.
26. Schumacher, M. A., C. J. Bashor, M. H. Song, K. Otsu, S. Zhu, R. J. Parry, B. Ullman, and R. G. Brennan. 2002. The structural mechanism of GTP stabilized oligomerization and catalytic activation of the Toxoplasma gondii uracil phosphoribosyltransferase. Proc. Natl. Acad. Sci. U. S. A. 99:78-83.
27. Siau, H., and D. Kerridge. 1999. 5-Fluorocytosine antagonizes the action of sterol biosynthesis inhibitors in Candida glabrata. J. Antimicrob. Chemother. 43:767-775.
28. Vandeputte, P., L. Pineau, G. Larcher, T. Noel, D. Brethes, D. Chabasse, and J.-P. Bouchara. 9 July 2010, posting date. Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata. Mycopathologia. [Epub ahead of print.] doi:10.1007/s11046-010-9342-1.
29. Vermes, A., H. J. Guchelaar, and J. Dankert. 2000. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46:171-179.
30. Vermitsky, J.-P., and T. D. Edlind. 2004. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48:3773-3781.
31. Vermitsky, J.-P., K. D. Earhart, W. L. Smith, R. Homayouni, T. D. Edlind, and P. D. Rogers. 2006. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol. Microbiol. 61:704-722.
32. Weber, E., C. Rodriguez, M. R. Chevallier, and R. Jund. 1990. The purine-cytosine permease gene of Saccharomyces cerevisiae: primary structure and deduced protein sequence of the FCY2 gene product. Mol. Microbiol. 4:585-596.
33. Whelan, W. L. 1987. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit. Rev. Microbiol. 15: 45-56.